F2RL1 and colorectal carcinoma: Collectively, these findings provide novel evidence demonstrating that curcumin can specifically target and downregulate the PAR-2 signaling axis in CRC cells under inflammatory conditions, impacting key downstream pathways involved in proliferation, survival, calcium homeostasis, and apoptosis.